Immediate Weight-Bearing Ankle Study

April 21, 2021 updated by: Fraser Orthopaedic Research Society

Immediate Unprotected Weight-Bearing and Range of Motion After Open Reduction and Internal Fixation of Unstable Ankle Fractures. A Historical Control Group Comparative Study

This single-centre historical control group comparative study will compare outcomes of surgically-treated rotational ankle fractures and the current routine practice of early protected weightbearing and range of motion with immediate unprotected weightbearing as tolerated and range of motion after ankle open reduction and internal fixation.

Study Overview

Status

Completed

Detailed Description

Ankle fractures are among the most common injuries, making up 9% of all fractures. Rotational ankle fractures are among the most common of all fractures, with an incidence averaging 4.2 per 1,000 individuals annually. These fractures range from minimal injuries amenable to non-surgical management to complex injuries with potential of long-term sequelae. Known risk factors for ankle fractures are age, body mass index and previous ankle fracture, with the highest incidence in elderly women.

Most ankle fractures are low-energy injuries which occur when the body rotates about a planted foot, whether it be during sports, normal gait, or otherwise. Stable ankle fractures are generally treated non-surgically, while unstable fractures are usually treated with surgical reduction and fixation, with indications previously well-described and published.

However, the post-operative management of such injuries is still controversial, with large variability between care providers. Protocols range from complete immobilization of the affected ankle and non-weightbearing to early range-of-motion (ROM) and weightbearing (WB). Studies have compared immobilization and non-WB to early ROM and WB but results have been mixed, with the most recent study demonstrating safety and advantages to protected WB and ROM at two weeks post-operatively versus non-WB and immobilization for six weeks.

The Investigators intend to expand on the studies above and propose a single-centre historical control group comparative study to compare outcomes of surgically-treated rotational ankle fractures and the current routine practice of early protected weightbearing and range of motion with immediate unprotected weightbearing as tolerated and range of motion after ankle open reduction and internal fixation.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • New Westminster, British Columbia, Canada, V3L 3M2
        • Royal Columbian Hospital / Fraser Health Authority

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • lateral malleolus fracture with talar shaft
  • vertical shear medial malleolus fracture without superior articular involvement
  • bimalleolar fracture
  • any ankle fracture with posterior malleolus fragment involving 25% or less of the articular surface on the lateral ankle radiograph
  • 43.B1 (pure split of distal tibia - but only if does not involve any of tibial plafond, i.e., only the vertical split of medial malleolus)
  • 44.A1 (Weber A)
  • 44.A2 (Bimalleolar)
  • 44.A3 (posterior malleolus involvement - but only if < 25% articular involvement on lateral x-ray)
  • 44-B1 (Isolated)
  • 44.B2 (with medial lesion)
  • 44.B3 (with medial lesion & Volkmann's #)
  • closed, Gustilo-Anderson Grade I or Grade II open fractures are included
  • willing and able to sign the consent
  • willing and able to follow the protocol and attend follow-up visits
  • able to read and understand English or have an interpreter available

Exclusion Criteria:

  • skeletal immaturity demonstrated radiographically by open physes
  • previous ipsilateral ankle surgery
  • bilateral ankle fractures
  • non ambulatory prior to injury
  • inability to comply with postoperative protocol (i.e., cognitive impairment)
  • medical comorbidity precluding surgery
  • poorly controlled diabetes (i.e. dense neuropathy / hx of ulcers / sensory deficit)
  • polytrauma patients (other injuries involving the ipsi/contralateral lower limbs, including the hip, that would interfere with mobilization/rehabilitation)
  • surgical date > 14 days (time of injury to OR)
  • Gustilo-Anderson grade III open fractures
  • tibial plafond fractures
  • active infection at the surgical site diagnosed clinically by the attending surgeon
  • any ankle fracture with posterior malleolus fragment involving more than 25% of the articular surface on the lateral ankle radiograph
  • any medial malleolus fracture involving the superior articular surface
  • any ankle fracture requiring syndesmosis fixation
  • any ankle fracture-dislocation
  • incarceration
  • likely problems, in the judgment of the investigator, with maintaining follow-up

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Late WB
Intervention: Patients receive a plaster splint in the operating room. They are not permitted to WB or ROM on the affected limb at this stage. At the first follow-up appointment (two weeks post-op), the splint is removed and a removable pre-fabricated walking boot applied. At this stage the patient is permitted to WB as tolerated while wearing the boot, and to perform ROM exercises with the boot removed. At six weeks post-op, the boot is discontinued and full unrestricted and unprotected weightbearing and ROM is permitted.

Post-0p: Non weight-bearing and no range of motion for 2 weeks post treatment. 2 weeks: Splint removed, removable pre-fabricated walking boot applied. WB as tolerated with boot, range of motion out of boot.

6 weeks: Boot discontinued and full unrestricted and unprotected WB and ROM permitted 6 weeks:

EXPERIMENTAL: Immediate unprotected WB and ROM
Patient do NOT receive a brace or splint of any kind. They are permitted to weightbear and range of motion as tolerated within the limitations of their own comfort. Use of ambulatory aids of any kind is permitted as needed without restrictions.
Weightbearing and range of motion as tolerated within the limitations of participant's own comfort. Use of ambulatory aides of any kind is permitted as needed without restriction. No brace or splint of any kind is permitted

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Olerud and Molander Score
Time Frame: 6 weeks post treatment
An assessment of symptoms after ankle fracture.
6 weeks post treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EQ-5D
Time Frame: 2, 6 and 12 weeks post treatment
Health Related quality of life outcome measure using five dimensions: Mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
2, 6 and 12 weeks post treatment
WPAI:SHP Work Productivity and Activity Impairment Questionnaire: Specific Health Problem
Time Frame: 2, 6 and 12 weeks post treatment
A questionnaire pertaining to the effect of the participant's ankle fracture on their ability to work and perform regular activities.
2, 6 and 12 weeks post treatment
Range of Motion
Time Frame: 2, 6 and 12 weeks post treatment
Amount of ankle dorsiflexion and plantarflexion (measured in degrees) as determined by goniometer assessment, as well as total arc of ankle ROM (dorsiflexion+ plantarflexion). This will be measured on both ankles for comparison.
2, 6 and 12 weeks post treatment
Wound Healing
Time Frame: 2, 6 and 12 weeks post treatment
Complications regarding the surgical wound, including but not limited to signs of infection or dehiscence.
2, 6 and 12 weeks post treatment
Fracture Healing
Time Frame: 2, 6 and 12 weeks post treatment
Radiographic assessment to determine healing, loss of reduction, loss of hardware fixation, or ankle alignment.
2, 6 and 12 weeks post treatment
Need for Re-operation
Time Frame: 2, 6 and 12 weeks post treatment
Any issue, whether it be a wound complication or fracture complication, requiring re-operation.
2, 6 and 12 weeks post treatment
Time to Return to Work
Time Frame: 2, 6 and 12 weeks post treatment
The chronological time between the date of surgery to the first day the participant returned to occupational duties, if currently employed and returns to work within the 12 weeks postoperative follow-up period. For the purposes of this study, students enrolled in educational activities will have their schooling treated as their occupational duty.
2, 6 and 12 weeks post treatment
Radiographic assessment
Time Frame: 2, 6 and 12 weeks post treatment
Assessment of alignment, hardware fixation, fracture reduction and loss of reduction (defined as any shft of 2mm or more in fracture position)
2, 6 and 12 weeks post treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Vu (Brian) Le, MD, FRSCS, Royal Columbian Hospital / Fraser Health Authority
  • Principal Investigator: Kelly L Apostle, MD, FRCSC, Royal Columbian Hospital / Fraser Health Authority

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 9, 2017

Primary Completion (ACTUAL)

January 18, 2021

Study Completion (ACTUAL)

January 18, 2021

Study Registration Dates

First Submitted

January 24, 2017

First Submitted That Met QC Criteria

January 24, 2017

First Posted (ESTIMATE)

January 26, 2017

Study Record Updates

Last Update Posted (ACTUAL)

April 23, 2021

Last Update Submitted That Met QC Criteria

April 21, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FHREB #: 2016-101

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on Late Rehabilitation

3
Subscribe